The shift to virtual conferences needs to be accompanied by a sensitivity to people in different time zones.

Europe's political shake-up is approaching - for researchers, key factors such as immigration and funding hang in the balance.

Unchecked ivermectin use in region is making it difficult to test anti-parasite drug's effectiveness against the coronavirus.

During a pandemic, more researchers might require support from colleagues and depend on those partnerships to collect the data they need to keep their labs operational. The article presents guidelines for collaborations.

Should academic science reconsider the definition of success?

Emmanuelle Charpentier and Jennifer Doudna share award for developing the precise genome-editing technology.

Face masks are vital to containing the spread of COVID, but lecturers and universities must find ways to be inclusive, say Olivier Pourret and Elodie Saillet.

The science supports that face coverings save lives, and yet the debate trundles on. How much evidence is enough?

Harvey Alter, Michael Houghton and Charles Rice share the award for research on a virus that causes hundreds of thousands of deaths a year.

The Howard Hughes Medical Institute is the second major US funder to mandate that the research it pays for must be free to read on publication.

Researchers will also recommend an open-access policy that promotes research being shared in online repositories.

Amy Coney Barrett is likely to influence the court on environmental regulation and scientific expertise, say legal scholars.

Public trust in a potential vaccine is under threat. Drug companies and their academic partners must disclose protocols and results data.

Immunization has always been a proxy for wider fears about social control, a history reminds us.

Months after infection with SARS-CoV-2, some people are still battling crushing fatigue, lung damage and other symptoms of 'long COVID'.

Researchers stress need for antenatal care, as emerging data link disrupted pregnancy services to increase in stillbirths.

Open letter flags results that appear to be duplicated and calls for access to the underlying data on the first COVID-19 vaccine to be approved for widespread use.

During the current COVID-19 pandemic, the concept of herd immunity has become a topic of much debate. This Comment examines the factors that determine it, discusses how far we have come and considers what it will take to reach herd immunity safely.

An advocacy group calls for funders and institutions to launch flexible grant and fellowship schemes and equity programmes.

The pandemic has worsened the plight of postdoctoral researchers. Funders need to be offering more than moral support.